More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

A research team is shedding new light on Bacillus Calmette-Guerin (BCG), a decades-old bladder cancer treatment, which is also given as vaccine against tuberculosis. The findings could help improve ...

A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...

New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while ...

Alan faced the prospect of losing his bladder when he was diagnosed with bladder cancer in 2020. Now he’s in remission thanks ...

A new review was published in Volume 16 of Oncotarget on May 19, 2025, titled “Advancements in bladder cancer treatment: The ...

Cancer remains one of the biggest health challenges of our lifetime. Millions of people globally receive a cancer diagnosis each year — in the United States, that’s about one diagnosis every 30 ...

A California cancer survivor was the recipient of the world's first in-human bladder transplant this month thanks to a pair ...

Urine for a breakthrough — in a true medical milestone, UCLA surgeons completed the world’s first in-human bladder transplant ...

When you’re young, the bladder is not something most people think about. However, as we age, what was once functional might ...